Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Hematologic Neoplasms × Busulfan × Clear all

Phase

Status

Completed 19 Terminated 5 Recruiting 3 Active not recruiting 3 Withdrawn 2 Not yet recruiting 2 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia 15 Leukemia, Myeloid, Acute 9 Precursor Cell Lymphoblastic Leukemia-Lymphoma 8 Lymphoma, Non-Hodgkin 8 Lymphoma 8 Multiple Myeloma 6 Myelodysplastic Syndromes 5 Lymphoma, Large B-Cell, Diffuse 5 Leukemia, Myeloid, Chronic-Phase 5 Neuroblastoma 4 Hodgkin Disease 4 Graft vs Host Disease 4 Congenital Abnormalities 4 Recurrence 3 Neoplasms, Plasma Cell 3 Lymphoma, Mantle-Cell 3 Lymphoma, Large-Cell, Immunoblastic 3 Lymphoma, Follicular 3 Leukemia, Myelomonocytic, Juvenile 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Burkitt Lymphoma 3 Sarcoma 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Neuroectodermal Tumors, Primitive, Peripheral 2 Lymphoma, Large-Cell, Anaplastic 2 Lymphoma, Extranodal NK-T-Cell 2 Lymphoma, B-Cell, Marginal Zone 2 Leukemia, Myelomonocytic, Acute 2 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 2 Leukemia, Myeloid, Accelerated Phase 2

Interventions

Cyclophosphamide 6 fludarabine 5 Exercise 4 Blood Specimen Collection 4 Immunotherapy, Adoptive 3 thymoglobulin 2 pegylated granulocyte colony-stimulating factor 2 Voriconazole 2 Surveys and Questionnaires 2 Stem Cell Transplantation 2 Physical Therapy Modalities 2 Parenteral Nutrition 2 Etoposide 2 Cytarabine 2 CF regimen 2 BNT162 Vaccine 2 Azacitidine 2 venetoclax 1 trihexyltetradecylphosphonium chloride 1 treosulfan 1 shengxuening 1 ruxolitinib 1 ramosetron 1 monalizumab 1 glucarpidase 1 fludarabine phosphate 1 ferrous succinate 1 eltrombopag 1 dexamethasone 21-phosphate 1 Whole-Body Irradiation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00750126 2011-01-19

RICE

University Hospital, Clermont-Ferrand

Phase 2 Unknown

Other hematologic neoplasm

Neoplasms, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡